Bio-pharmaceutical logistics market seen topping $257.81 billion by 2030

The Business Research Company says the bio-pharmaceutical logistics market will exceed $257.81 billion by 2030, driven by cold chain demand, biologics growth and digital tracking tools. DHL is listed as the largest market share holder in a fragmented field where cold chain logistics is expected to dominate.

Why it matters: - Bio-pharmaceutical logistics is becoming a bigger piece of global pharma supply chains as more biologics, vaccines and cell and gene therapies need tightly controlled transport and storage. - The market’s growth points to rising demand for cold chain capacity, traceability and specialized handling across commercial distribution and clinical trials. - The report forecasts the market will exceed $257.81 billion by 2030. - Cold chain logistics is expected to represent 69% of the market, or about $178 billion, by 2030.

What happened: - The Business Research Company published a bio-pharmaceutical logistics market report covering 2026-2035 forecasts and 2030 market sizing. - DHL is listed as the largest market-share holder in 2025 at 2%, alongside several other global logistics companies at similar or slightly lower levels. - North America is projected to be the largest regional market in 2030 at $92 billion, up from $61 billion in 2025. - The United States is projected to be the largest national market in 2030 at $82 billion, up from $55 billion in 2025. - The company posted sample and full-report links: More information and the full report.

The details: - The report says temperature-controlled logistics is a main growth driver because biologics, vaccines, specialty medicines and cell and gene therapies need strict temperature regulation. - It estimates temperature-controlled logistics will add about 2.8% annual growth to the market. - Global expansion in biologics and vaccine distribution is projected to add about 2.6% annual growth. - IoT sensors, GPS tracking and digital platforms are adding real-time shipment visibility, temperature control and compliance support, contributing roughly 2.4% annual growth. - Cold chain logistics is forecast to dominate because of temperature-sensitive therapies that require insulated packaging, continuous monitoring and Good Distribution Practice compliance. - The broader market is segmented into cold chain logistics and non-cold chain logistics, plus transportation, warehousing and distribution, and value-added services. - Application segments include ground shipping, sea shipping and air shipping. - End users include pharmaceutical and biopharmaceutical companies, pharmacies, hospitals, clinics and other healthcare providers. - The top 10 players controlled about 14% of total revenue in 2025, indicating a fragmented market. - Market barriers include strict pharmaceutical transportation standards, cold chain requirements and specialized handling needs.

Between the lines: - The market structure favors companies that can combine global reach with validated cold chain infrastructure and digital visibility. - The report’s concentration data suggests no single provider has overwhelming control, which leaves room for regional specialists and niche cold chain operators. - Innovation appears centered on reusable, IoT-enabled packaging and data-rich shipment monitoring rather than only on trucks, planes and warehouses. - Cold Chain Technologies LLC introduced its CCT tower elite in April 2025, a reusable, IoT-enabled temperature-controlled pallet shipper for pharmaceutical and biotech products. - The move toward real-time monitoring and predictive risk management reflects a shift from simple transport to tightly managed product integrity.

What's next: - The report expects cold chain and non-cold chain logistics together to add more than $101 billion in market value from 2025 to 2030. - Cold chain logistics is expected to contribute $70 billion of that increase, while non-cold chain logistics adds $31 billion. - The company expects further strategic collaborations, infrastructure expansion and regional growth as demand for temperature-controlled logistics rises. - Companies named in the report are likely to keep investing in IoT monitoring, AI-driven analytics, packaging and cold chain networks.

The bottom line: - Bio-pharmaceutical logistics is shifting from a specialist support function into a high-growth global market built on cold chain precision, digital tracking and regulatory compliance.